Cargando…
Treatment of Oligometastatic Hormone-Sensitive Prostate Cancer: A Comprehensive Review
With advancements in diagnostic techniques, including molecular and clinical imaging, that directly target cancer cells, oligometastatic prostate cancer (PCa) is being diagnosed in patients who were, in the past, considered to have localized disease. With accumulating evidence, there has been a para...
Autores principales: | Koo, Kyo Chul, Dasgupta, Prokar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990677/ https://www.ncbi.nlm.nih.gov/pubmed/29869454 http://dx.doi.org/10.3349/ymj.2018.59.5.567 |
Ejemplares similares
-
Recent Advances in the Management of Hormone-Sensitive Oligometastatic Prostate Cancer
por: Marvaso, Giulia, et al.
Publicado: (2022) -
Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancer
por: Preisser, Felix, et al.
Publicado: (2021) -
The role of hormone therapy and chemotherapy in oligometastatic prostate cancer
por: Miura, Yuji, et al.
Publicado: (2019) -
Where Do We Stand in the Management of Oligometastatic Prostate Cancer? A Comprehensive Review
por: Juan, Gómez Rivas, et al.
Publicado: (2022) -
Current Status and Application of Metformin for Prostate Cancer: A Comprehensive Review
por: Ahn, Hyun Kyu, et al.
Publicado: (2020)